Eisenberg P R, Hansbrough J R, Anderson D, Schuster D P
Am Rev Respir Dis. 1987 Sep;136(3):662-8. doi: 10.1164/ajrccm/136.3.662.
We prospectively evaluated a protocol that included extravascular thermal volume (ETV) as a measure of extravascular lung water (EVLW) instead of pulmonary artery wedge pressure (Ppaw) measurements to guide the hemodynamic management of 48 critically ill patients. Patients were randomized to either a protocol management (PM), or to a routine management (RM) group. In the RM group, EVLW measurements were unknown to the primary care physicians. The 2 groups were similar with respect to age, gender, and severity of illness. In patients with initially high EVLW, EVLW fell to a greater extent in PM than in RM patients (18 +/- 5 versus 4 +/- 8% decrease, p less than 0.05). This difference was even greater in patients with heart failure. No adverse effects on oxygenation or renal function occurred in following the protocol. Mortality for the groups as a whole was similar, but was significantly better (p less than 0.05) for PM patients with initially high EVLW and normal Ppaw (predominantly patients with sepsis or the adult respiratory distress syndrome). For both groups, patients with an initial EVLW greater than 14 ml/kg had a significantly greater mortality than did those with a lesser amount of EVLW: 13 of 15 (87%) versus 13 of 32 (41%), p less than 0.05. We conclude that management based on a protocol using EVLW measurements is safe, may hasten the resolution of pulmonary edema, and may lead to improved outcome in some critically ill patients.
我们前瞻性地评估了一种方案,该方案采用血管外热容量(ETV)作为血管外肺水(EVLW)的测量指标,而非肺动脉楔压(Ppaw)测量值,以指导48例危重症患者的血流动力学管理。患者被随机分为方案管理(PM)组或常规管理(RM)组。在RM组中,初级保健医生不知道EVLW的测量值。两组在年龄、性别和疾病严重程度方面相似。在初始EVLW较高的患者中,PM组患者的EVLW下降幅度大于RM组患者(分别下降18±5%和4±8%,p<0.05)。这种差异在心力衰竭患者中更为明显。遵循该方案未对氧合或肾功能产生不良影响。两组总体死亡率相似,但对于初始EVLW较高且Ppaw正常的PM组患者(主要是脓毒症或成人呼吸窘迫综合征患者),死亡率显著更低(p<0.05)。对于两组,初始EVLW大于14 ml/kg的患者死亡率显著高于EVLW较低的患者:15例中有13例(87%),而32例中有13例(41%),p<0.05。我们得出结论,基于使用EVLW测量值的方案进行管理是安全的,可能会加速肺水肿的消退,并可能改善一些危重症患者的预后。